Dna X (SONM) Free Cash Flow (2018 - 2026)

Dna X (SONM) has 9 years of Free Cash Flow data on file, last reported at -$3.5 million in Q1 2026.

• Quarterly Free Cash Flow rose 63.92% year-over-year to -$3.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$17.4 million (up 3.99% YoY) and the FY2025 annual result came in at -$23.5 million, down 170.41% from the prior year.
• Free Cash Flow fell to -$3.5 million in Q1 2026, from -$2.0 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $820000.0 in Q2 2023 to a low of -$10.3 million in Q3 2022.
• A 5-year average of -$3.1 million and a median of -$2.2 million in 2022 frame the typical range for Free Cash Flow.
• Annual changes were most pronounced in 2022 — Free Cash Flow soared 110.86% — and 2025, when it tumbled 4751.52%.
• Tracing SONM's Free Cash Flow over 5 years: stood at -$2.2 million in 2022, then soared by 83.69% to -$363000.0 in 2023, then plunged by 1144.35% to -$4.5 million in 2024, then soared by 55.63% to -$2.0 million in 2025, then plunged by 72.95% to -$3.5 million in 2026.
• The last three Free Cash Flow figures came in at -$3.5 million (Q1 2026), -$2.0 million (Q4 2025), and -$7.0 million (Q3 2025), per Business Quant data.